Drug Pipeline

AZD6234 Clinical Trials

Name: AZD6234 clinical trials — 4 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-04	NCT06862791 A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in…	Trial completed

Active Studies by Phase

Phase 2

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT07017179	This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With…	Obesity/Overweight	Recruiting
NCT06851858	Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or…	Endocrinology	Active, Not Recruiting
Phase 1
NCT07013643	A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and…	Healthy Participants	Recruiting
NCT07546760	A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234	Hepatic Impairment	Recruiting

Sponsors Running AZD6234 Trials

AstraZeneca (4)

Disease Areas

Obesity (2) Diabetes (1)

Get alerts when AZD6234 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.